Jennison Associates was founded in 1969 on a belief that is as true today as it was then: Doing what’s right for clients will always be good for business. Our success in achieving client investment objectives has been made possible by our distinct investment-focused culture. The bedrock of our success, it remains firmly rooted in everything we do. We are, and always have been, distinguished by professional excellence, client focus, teamwork, and experience. For more than 50 years, we have successfully applied our investment principles to build insights and judgment that help us identify opportunities and construct portfolios. We believe that long-term excess returns can be achieved by identifying and investing in market-leading opportunities. Many factors cause variability in the way markets price securities in the short term. Our job is to assess how these factors affect our investment thesis and long-term value.
Managing Director, Portfolio Manager
I am the portfolio manager of a Healthcare focused mutual fund and hedge fund at Jennison Associates. This means that I am responsible for picking all of the stocks (both long and short) that get included in the portfolios. I have worked at Jennison for over 18 years. I started as an analyst and became a portfolio manager in 2015. In addition to managing the Healthcare portfolios, I continue to work across the firm guiding many of the other funds on their Healthcare stock selections. These include: the Large Cap Growth, Global Equity, SMALL, SMID and MID Cap portfolios.
Ever wonder what it’s actually like to work on Wall Street? By the end of this day, you’ll know the difference between the Buy Side and the Sell Side of the investment world — and you’ll have met real people doing these jobs every day. We’ll kick off the morning at Evercore, one of the top investment banks, sitting in on their morning meeting — the same one that sets the tone for their entire trading day. From there, we’ll meet with Evercore’s Sales and Trading team to see how deals get done in real time. Then we’ll spend time with Umer Raffat, the #1 Institutional Investor-ranked Biopharma analyst on the Sell Side, and his team — these are the people moving markets with their research. After that, we’ll head downstairs to my firm, Jennison, where I’ll give you a look at life on the Buy Side and how we think about putting capital to work. Throughout the day, I’ll bring in additional speakers across different Buy Side and Sell Side roles, including a panel of recent college grads who will share how they broke into the industry and what they wish they’d known earlier. It’s a packed day — but by the time we wrap up, you’ll walk away with a real understanding of how this industry works and the kind of access that’s hard to get anywhere else.
